The Novel Fusion Protein Melittin‐MIL‐2 Exhibits Strong Antitumor Immune Effect in Lung Adenocarcinoma Cell A549
ABSTRACT In previous studies, we developed a novel fusion protein named “melittin‐MIL‐2” which exhibited more anti‐tumor activity. However, it remains unclear whether melittin‐MIL‐2 possesses antitumor immune effect on lung adenocarcinoma. In this study, the immune effect and mechanism of melittin‐M...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2024-07-01
|
| Col·lecció: | The Clinical Respiratory Journal |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1111/crj.13805 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|